The FDA has issued a Public Health Advisory for Adderall and Adderall XR.
The FDA says that "Adderall XR is a controlled release amphetamine used to treat patients with Attention Deficit Hyperactivity Disorder (ADHD)."
The FDA also notes: "Health Canada has suspended marketing of Adderall XR products from the Canadian market due to concern about reports of sudden unexplained death (SUD) in children taking Adderall and Adderall XR. SUD has been associated with amphetamine abuse and reported in children with underlying cardiac abnormalities taking recommended doses of amphetamines, including Adderall and Adderall XR. In addition, a very small number of cases of SUD have been reported in children without structural cardiac abnormalities taking Adderall. At this time, FDA cannot conclude that recommended doses of Adderall can cause SUD, but is continuing to carefully evaluate these data."
If you have taken Adderall® and have concerns, learn more about your options and get an Instant Answer to your questions. Call today and speak with an Attorney: 1.800.838.0800.
Burke & Eisner Law Blogs
